2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
 The invention encompasses the novel compound of Formula I as well as a method of treating cyclooxygenase-2 mediated diseases comprising administration to a patient in need of such treatment of a non-toxic therapeutically effective amount of a compound of Formula I. ##STR1## The invention also encompasses certain pharmaceutical compositions for treatment of cyclooxygenase-2 mediated diseases comprising compounds of Formula I. 
Merck Frosst Canada & Co.
C C C
C07D C07D C07D
inventional inventional inventional
Daniel Rejean Denis Richard
Dube Fortin Deschenes Friesen